Cargando…

Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator

Continuous manufacturing is becoming the new technological standard in the pharmaceutical industry. In this work, a twin-screw processor was employed for the continuous production of liquisolid tablets containing either simethicone or a combination of simethicone with loperamide hydrochloride. Both...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakowiecki, Daniel, Richter, Margarethe, Yuece, Ceren, Voelp, Annika, Ries, Maximilian, Papaioannou, Markos, Edinger, Peter, Hess, Tobias, Mojsiewicz-Pieńkowska, Krystyna, Cal, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142538/
https://www.ncbi.nlm.nih.gov/pubmed/37111750
http://dx.doi.org/10.3390/pharmaceutics15041265
_version_ 1785033636723032064
author Zakowiecki, Daniel
Richter, Margarethe
Yuece, Ceren
Voelp, Annika
Ries, Maximilian
Papaioannou, Markos
Edinger, Peter
Hess, Tobias
Mojsiewicz-Pieńkowska, Krystyna
Cal, Krzysztof
author_facet Zakowiecki, Daniel
Richter, Margarethe
Yuece, Ceren
Voelp, Annika
Ries, Maximilian
Papaioannou, Markos
Edinger, Peter
Hess, Tobias
Mojsiewicz-Pieńkowska, Krystyna
Cal, Krzysztof
author_sort Zakowiecki, Daniel
collection PubMed
description Continuous manufacturing is becoming the new technological standard in the pharmaceutical industry. In this work, a twin-screw processor was employed for the continuous production of liquisolid tablets containing either simethicone or a combination of simethicone with loperamide hydrochloride. Both active ingredients present major technological challenges, as simethicone is a liquid, oily substance, and loperamide hydrochloride was used in a very small amount (0.27% w/w). Despite these difficulties, the use of porous tribasic calcium phosphate as a carrier and the adjustment of the settings of the twin-screw processor enabled the optimization of the characteristics of the liquid-loaded powders and made it possible to efficiently produce liquisolid tablets with advantages in physical and functional properties. The application of chemical imaging by means of Raman spectroscopy allowed for the visualization of differences in the distribution of individual components of the formulations. This proved to be a very effective tool for identifying the optimum technology to produce a drug product.
format Online
Article
Text
id pubmed-10142538
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101425382023-04-29 Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator Zakowiecki, Daniel Richter, Margarethe Yuece, Ceren Voelp, Annika Ries, Maximilian Papaioannou, Markos Edinger, Peter Hess, Tobias Mojsiewicz-Pieńkowska, Krystyna Cal, Krzysztof Pharmaceutics Article Continuous manufacturing is becoming the new technological standard in the pharmaceutical industry. In this work, a twin-screw processor was employed for the continuous production of liquisolid tablets containing either simethicone or a combination of simethicone with loperamide hydrochloride. Both active ingredients present major technological challenges, as simethicone is a liquid, oily substance, and loperamide hydrochloride was used in a very small amount (0.27% w/w). Despite these difficulties, the use of porous tribasic calcium phosphate as a carrier and the adjustment of the settings of the twin-screw processor enabled the optimization of the characteristics of the liquid-loaded powders and made it possible to efficiently produce liquisolid tablets with advantages in physical and functional properties. The application of chemical imaging by means of Raman spectroscopy allowed for the visualization of differences in the distribution of individual components of the formulations. This proved to be a very effective tool for identifying the optimum technology to produce a drug product. MDPI 2023-04-18 /pmc/articles/PMC10142538/ /pubmed/37111750 http://dx.doi.org/10.3390/pharmaceutics15041265 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zakowiecki, Daniel
Richter, Margarethe
Yuece, Ceren
Voelp, Annika
Ries, Maximilian
Papaioannou, Markos
Edinger, Peter
Hess, Tobias
Mojsiewicz-Pieńkowska, Krystyna
Cal, Krzysztof
Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator
title Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator
title_full Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator
title_fullStr Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator
title_full_unstemmed Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator
title_short Towards the Continuous Manufacturing of Liquisolid Tablets Containing Simethicone and Loperamide Hydrochloride with the Use of a Twin-Screw Granulator
title_sort towards the continuous manufacturing of liquisolid tablets containing simethicone and loperamide hydrochloride with the use of a twin-screw granulator
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142538/
https://www.ncbi.nlm.nih.gov/pubmed/37111750
http://dx.doi.org/10.3390/pharmaceutics15041265
work_keys_str_mv AT zakowieckidaniel towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT richtermargarethe towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT yuececeren towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT voelpannika towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT riesmaximilian towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT papaioannoumarkos towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT edingerpeter towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT hesstobias towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT mojsiewiczpienkowskakrystyna towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator
AT calkrzysztof towardsthecontinuousmanufacturingofliquisolidtabletscontainingsimethiconeandloperamidehydrochloridewiththeuseofatwinscrewgranulator